Objectives

After participating in this educational activity, attendees should be able to:

  1. Review the biochemical signatures of syndromes not detected by routine neonatal screening for hypothyroidism.
  2. Utility of thyroid hormone analogues in the treatment of thyroid hormone cell transport defect.
  3. Why treatment should start prior to birth.
  4. The possible application of gene therapy in postnatal life.

 

 

Faculty

Samuel Refetoff, M.D.
Professor of Pediatrics and Committee on Genetics
Director of the Endocrinology Laboratory and The Thyroid Study Unit
The University of Chicago,

 

Faculty Disclosure

The design and content of Baystate Continuing Interprofessional Education ( CE ) activities support quality improvement in healthcare and provide fair and balanced views of therapeutic options.  Faculty or planner conflicts of interest are resolved before the educational activity.

None of the members of the faculty and planning committee for this educational event have commercial relationships with any entity producing, marketing, re-selling or distributing health care goods and services consumed by or used on patients.

                                                                             

Session date: 
Tuesday, February 2, 2021 - 12:00pm to 1:00pm
Location: 
MA
United States
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 ANCC Contact Hours
  • 1.00 BCIPE Instructional Hours

Please login or register to take this course.